After 12 years’ waiting, the 4th version of the Patent Law with an aim of further motivating innovations and improving the mechanism for cracking down patent infringements was finally passed on October 17, 2020. The amended Chinese patent law will take effect on June 1, 2021. Second Amendments introduced pharmaceutical patent-term extensions and established an early pharmaceutical patent-dispute resolution mechanism and patent linkage system that further protects the rights of patentees.

The European Chamber is delighted to invite Ms Mi LI, Principal at Rouse and the IP Consulting Director of Rouse China in Beijing to break down the changes and challenges, as well as outlooks ahead for our members in the pharmaceutical sector.

• 2020-11-20 | 14:00 - 15:40
• Zoom Online Meeting & Rouse Office

Pharmaceutical and Compliance & Business Ethics Joint Working Group Meeting: Discussion on the Administrative Measures of Medical Representative Registration (Trial)

• 2020-11-17 | 09:00 - 10:30
• European Chamber Beijing Office

In a much-anticipated announcement, the National People's Congress released for public consultation on 3rd July the second draft amendments to the Patent Law. Significant changes include the introduction of a Patent Linkage system and a Supplemental Protection Period. These issues have long been discussed but there had been no further information released since the Supplemental Protection Period had been included in the previous draft on 4th January 2019.

The draft amendments to the Patent Law are open for public opinion until 16th August 2020. If you would like to send in comments through the chamber, please kindly submit your comments to sthe@europeanchamber.com.cn by 7th August.

The European Chamber is delighted to invite Ms Katherine Wang, Partner of Ropes & Gray life science group, to provide our members with a brief introduction on the second draft amendments of the Patent Law, with a focus on measures especially related to the pharmaceutical sectors.

• 2020-07-30 | 11:30 - 13:00
• Zoom online meeting

Pharmaceutical Working Group Meeting: Presentation on the Understanding and Reflection of National Health Insurance Negotiation (Chinese language only) 关于国家医保谈判的认识和思考 （中文会议）

• 2020-07-22 | 09:30 - 11:00
• online

E-signature has become an important formality vehicle for entering into commercial contracts worldwide. What are e-signature’s implication and enforceability in Chinese commercial and judicial world? The European Chamber is delighted to invite you to our next working group meeting where Mr. HE Fang, partner of King & Wood Mallesons will present on the e-signature and Chinese e-signature law by sharing some real-life court cases.

• 2020-07-03 | 10:00 - 11:30
• Online (ZOOM) & Onsite(Beijing Chamber Office)

Pharmaceutical Working Group Meeting > Dialogue with Hainan Medical Products Administration (Chinese language only)

• 2020-07-03 | 14:30 - 16:00
• Zoom Online Meeting

The European Chamber is delighted to invite you to a joint working group meeting on the updates of the Classified Cyber-security Protection Scheme (CCPS) and other related cyber-security laws and regulations with Mr. Wang Xinjie, CEO if Power Times and Member of the SAC/TC260, and Mr. He Ruijun, Managing editor of Joint Publishing Centre between PT Press/Taylor & Francis Group.

• 2020-06-16 | 14:00 - 15:35
• European Chamber Office Beijing C405

Medical resource shortages are increasingly challenging for many countries battling the COVID-19 pandemic. In response to the need, various companies are donating money, personal protective equipment (PPE), ventilators, medicines, disinfectants, food, and other valuable resources. Compliance risks should be carefully considered when providing this valuable assistance to ensure that the resources are put in the right hands with no strings attached. Meanwhile, during the COVID-19 outbreak, the government offers various subsidies to support foreign businesses. Government subsidies beneficiaries face the potential risk of non-compliance.

The European Chamber is delighted to invite Simon Hui, Lead Partner of Baker & McKenzie LLP to share his experience and insights to help our member companies to stay compliant during this special time. The meeting will cover the below topics:

1. Overview of legal requirements under PRC Law
2. Regulatory framework under FCPA, UKBA and France Sapin II Law
3. Industry specific requirements in the medical industry
4. Identify and manage risks arising from donation and government subsidies
5. Case study

Agenda

15:00 – 15:05 Opening by chamber representative
15:05 – 16:00 Presentation by Mr. Simon Hui, Lead Partner of Baker & McKenzie LLP
16:00 – 16:30 Q&A Session

• 2020-05-26 | 15:00 - 16:30
• Zoom Online Meeting

Both the air freight and shipping industries are currently running into some turbulence. The air freight industry is being buffeted by the increasing winds of change and the shipping industry has to deal with the surge in rogue waves, both sparked by the outset of the COVID-19 global crisis.
Experts on both the air freight and shipping industries will present the current state of affairs, ways to cope with the situation and the possible future developments.

• 2020-04-30 | 14:00 - 16:00
• Online - Zoom (Link to be sent upon confirmation)

Joint Pharmaceutical and Compliance Working Group Meeting: Presentation on the Digitalization of China’s Healthcare Industry

• 2020-04-08 | 14:00 - 16:00
• Beijing, online